Difference between revisions of "Team:TNCR Korea/Contribution"

 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
−
{{TNCR_Korea}}
 
 
<html>
 
<html>
  
 +
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
 +
<!--[if IE 7]>        <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
 +
<!--[if IE 8]>        <html class="no-js lt-ie9"> <![endif]-->
 +
<!--[if gt IE 8]><!--> <html class="no-js"> <!--<![endif]-->
 +
<head>
 +
<meta charset="utf-8">
 +
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 +
<title>TNCR_KOREA &mdash; Digestable Gluten</title>
 +
<meta name="viewport" content="width=device-width, initial-scale=1">
 +
<meta name="description" content="Free HTML5 Template by FREEHTML5.CO" />
 +
<meta name="keywords" content="free html5, free template, free bootstrap, html5, css3, mobile first, responsive" />
 +
<meta name="author" content="FREEHTML5.CO" />
  
−
<div class="column full_size">
 
−
<h1>Contribution</h1>
 
−
<h3>Bronze Medal Criterion #4</h3>
 
−
<p><b>Standard Tracks:</b> Participate in the Interlab Measurement Study (to be documented on your InterLab page) and/or improve the characterization of an existing BioBrick Part or Device and enter this information on that part's Main Page in the Registry. The part that you are characterizing must NOT be from a 2017 part number range. Teams who are working on improving the characterization of an existing part should document their experimental design here, along with an explanation for why they chose that part to improve. Data can also be shown here, but it MUST also be documented on the part's Main Page in the Registry.
 
−
<br><br>
 
−
<b>Special Tracks:</b> Document at least one new substantial contribution to the iGEM community that showcases a project related to BioBricks. This contribution should be central to your project and equivalent in difficulty to making and submitting a BioBrick part.
 
  
 +
<meta property="og:title" content=""/>
 +
<meta property="og:image" content=""/>
 +
<meta property="og:url" content=""/>
 +
<meta property="og:site_name" content=""/>
 +
<meta property="og:description" content=""/>
 +
<meta name="twitter:title" content="" />
 +
<meta name="twitter:image" content="" />
 +
<meta name="twitter:url" content="" />
 +
<meta name="twitter:card" content="" />
 +
 +
 +
<link rel="shortcut icon" href="favicon.ico">
 +
 +
<link href='https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,300' rel='stylesheet' type='text/css'>
 +
 +
<!-- Animate.css -->
 +
<link rel="stylesheet" type="text/css" href="https://2017.igem.org/Template:TNCR_Korea_animate/CSS?action=raw&ctype=text/css">
 +
<!-- Icomoon Icon Fonts-->
 +
<link rel="stylesheet" type="text/css" href="https://2017.igem.org/Template:TNCR_Korea_icomoon/CSS?action=raw&ctype=text/css">
 +
<!-- Bootstrap  -->
 +
<link rel="stylesheet" type="text/css"  href="https://2017.igem.org/Template:TNCR_Korea_bootstrap/CSS?action=raw&ctype=text/css">
 +
<!-- Superfish -->
 +
<link rel="stylesheet" type="text/css" href="https://2017.igem.org/Template:TNCR_Korea_superfish/CSS?action=raw&ctype=text/css">
 +
 +
<link rel="stylesheet" type="text/css" href="https://2017.igem.org/Template:TNCR_Korea_style/CSS?action=raw&ctype=text/css">
 +
 +
 +
<!-- Modernizr JS -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_modernizr/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<!-- FOR IE9 below -->
 +
<!--[if lt IE 9]>
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_respond/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<![endif]-->
 +
 +
 +
 +
<style>
 +
 +
 +
 +
 +
/***************************************************** DEFAULT WIKI SETTINGS  ****************************************************/
 +
 +
/* Clear the default wiki settings */
 +
 +
#home_logo, #sideMenu { display:none; }
 +
#sideMenu, #top_title, .patrollink  {display:none;}
 +
#content { width:100%; padding: 0px;  margin-top:-7px; margin-left:0px;}
 +
body {background-color:white; }
 +
#bodyContent h1, #bodyContent h2, #bodyContent h3, #bodyContent h4, #bodyContent h5 { margin-bottom: 0px; }
 +
 +
 +
 +
#top_menu_under {
 +
    position: relative;
 +
    width: 100%;
 +
    /* height: 18px; */
 +
}
 +
 +
#fh5co-primary-menu li{
 +
display: inline
 +
}
 +
 +
 +
 +
 +
#fh5co-menu-wrap {
 +
  position: relative;
 +
  z-index: 2;
 +
  display: block;
 +
  float: right;
 +
  margin-top: 60px;
 +
}
 +
 +
#fh5co-menu-wrap .sf-menu a {
 +
  padding: 1em .75em;
 +
}
 +
 +
#fh5co-primary-menu > li > ul li.active > a {
 +
  color: #FCC72C !important;
 +
}
 +
#fh5co-primary-menu > li > .sf-with-ul:after {
 +
  border: none !important;
 +
  font-family: 'icomoon';
 +
  speak: none;
 +
  font-style: normal;
 +
  font-weight: normal;
 +
  font-variant: normal;
 +
  text-transform: none;
 +
  line-height: 1;
 +
  /* Better Font Rendering =========== */
 +
  -webkit-font-smoothing: antialiased;
 +
  -moz-osx-font-smoothing: grayscale;
 +
  position: absolute;
 +
  float: right;
 +
  margin-right: -5px;
 +
  top: 50%;
 +
  margin-top: -7px;
 +
  content: "\e922";
 +
  color: rgba(255, 255, 255, 0.5);
 +
}
 +
#fh5co-primary-menu > li > ul li {
 +
  position: relative;
 +
}
 +
 +
 +
#fh5co-primary-menu > li > ul li > .sf-with-ul:after {
 +
  border: none !important;
 +
  font-family: 'icomoon';
 +
  speak: none;
 +
  font-style: normal;
 +
  font-weight: normal;
 +
  font-variant: normal;
 +
  text-transform: none;
 +
  line-height: 1;
 +
  /* Better Font Rendering =========== */
 +
  -webkit-font-smoothing: antialiased;
 +
  -moz-osx-font-smoothing: grayscale;
 +
  position: absolute;
 +
  float: right;
 +
  margin-right: 10px;
 +
  top: 20px;
 +
  font-size: 16px;
 +
  content: "\e924";
 +
  color: rgba(0, 0, 0, 0.5);
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu {
 +
  padding: 10px 7px 10px;
 +
  background: #fff;
 +
  left: 0;
 +
  -webkit-border-radius: 5px;
 +
  -moz-border-radius: 5px;
 +
  -ms-border-radius: 5px;
 +
  border-radius: 5px;
 +
  -webkit-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.15);
 +
  -moz-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.15);
 +
  -ms-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.15);
 +
  -o-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.15);
 +
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.15);
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu > li > .fh5co-sub-menu {
 +
  left: 100%;
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu:before {
 +
  position: absolute;
 +
  top: -9px;
 +
  left: 20px;
 +
  width: 0;
 +
  height: 0;
 +
  content: '';
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu:after {
 +
  position: absolute;
 +
  top: -8px;
 +
  left: 21px;
 +
  width: 0;
 +
  height: 0;
 +
  border-right: 8px solid transparent;
 +
  border-bottom: 8px solid #fff;
 +
  border-bottom: 8px solid white;
 +
  border-left: 8px solid transparent;
 +
  content: '';
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu .fh5co-sub-menu:before {
 +
  top: 6px;
 +
  left: 100%;
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu .fh5co-sub-menu:after {
 +
  top: 7px;
 +
  right: 100%;
 +
  border: none !important;
 +
}
 +
 +
.site-header.has-image #primary-menu .sub-menu {
 +
  border-color: #ebebeb;
 +
  -webkit-box-shadow: 0 5px 15px 4px rgba(0, 0, 0, 0.09);
 +
  -moz-box-shadow: 0 5px 15px 4px rgba(0, 0, 0, 0.09);
 +
  -ms-box-shadow: 0 5px 15px 4px rgba(0, 0, 0, 0.09);
 +
  -o-box-shadow: 0 5px 15px 4px rgba(0, 0, 0, 0.09);
 +
  box-shadow: 0 5px 15px 4px rgba(0, 0, 0, 0.09);
 +
}
 +
.site-header.has-image #primary-menu .sub-menu:before {
 +
  display: none;
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu a {
 +
  letter-spacing: 0;
 +
  padding: 0 15px;
 +
  font-size: 18px;
 +
  line-height: 34px;
 +
  color: #575757 !important;
 +
  text-transform: none;
 +
  background: none;
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu li {
 +
  display: block;
 +
}
 +
 +
#fh5co-primary-menu .fh5co-sub-menu a:hover {
 +
  color: #FCC72C !important;
 +
}
 +
 +
#fh5co-work-section,
 +
#fh5co-services-section,
 +
#fh5co-content-section,
 +
#fh5co-work-section_2,
 +
#fh5co-blog-section {
 +
  padding: 7em 0;
 +
}
 +
@media screen and (max-width: 768px) {
 +
  #fh5co-work-section,
 +
  #fh5co-services-section,
 +
  #fh5co-content-section,
 +
  #fh5co-work-section_2,
 +
  #fh5co-blog-section {
 +
    padding: 4em 0;
 +
  }
 +
}
 +
 +
 +
</style>
 +
 +
 +
<!--- THIS IS WHERE THE HTML BEGINS --->
 +
 +
</head>
 +
<body>
 +
<div id="fh5co-wrapper">
 +
<div id="fh5co-page">
 +
<div id="fh5co-header">
 +
<header id="fh5co-header-section">
 +
<div class="container">
 +
<div class="nav-header">
 +
<a href="#" class="js-fh5co-nav-toggle fh5co-nav-toggle"><i></i></a>
 +
<h1 id="fh5co-logo"><a href="https://2017.igem.org/Team:TNCR_Korea"><span>TNCR</span>KOREA</a></h1>
 +
<!-- START #fh5co-menu-wrap -->
 +
<nav id="fh5co-menu-wrap" role="navigation">
 +
<ul class="sf-menu" id="fh5co-primary-menu">
 +
<li>
 +
<a href="https://2017.igem.org/Team:TNCR_Korea">Home</a>
 +
</li>
 +
<li>
 +
<a href="portfolio.html" class="fh5co-sub-ddown">Team</a>
 +
<ul class="fh5co-sub-menu">
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Team" target="_blank">Team</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Attributions" target="_blank">Attributions</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Collaborations" target="_blank">Collaborations</a></li>
 +
</ul>
 +
</li>
 +
<li>
 +
<a href="portfolio.html" class="fh5co-sub-ddown">Project</a>
 +
<ul class="fh5co-sub-menu">
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Background" target="_blank">Background</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Description" target="_blank">Description</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Design" target="_blank">Design</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Model" target="_blank">Model</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Experiments" target="_blank">Experiments</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Notebook" target="_blank">Notebook</a></li>
 +
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Results" target="_blank">Results</a></li>
 +
</ul>
 +
</li>
 +
<li class="active">
 +
<a href="portfolio.html" class="fh5co-sub-ddown">Parts</a>
 +
<ul class="fh5co-sub-menu">
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Parts" target="_blank">Parts</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Contribution" target="_blank">Contribution</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Basic_Part" target="_blank">Basic Part</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Composite_Part" target="_blank">Composite Part</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Part_Collection" target="_blank">Part Collection</a></li>
 +
</ul>
 +
</li>
 +
<li>
 +
<a href="portfolio.html" class="fh5co-sub-ddown">Human Practices</a>
 +
<ul class="fh5co-sub-menu">
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/HP/Silver" target="_blank">Human Activity</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/HP/Gold_Integrated" target="_blank">Integrated Human Activity</a></li>
 +
<li><a href="https://2017.igem.org/Team:TNCR_Korea/Engagement" target="_blank">Public Engagement</a></li>
 +
</ul>
 +
</li>
 +
<li>
 +
<a href="https://2017.igem.org/Team:TNCR_Korea/Awards">Awards</a>
 +
</li>
 +
</ul>
 +
</nav>
 +
</div>
 +
</div>
 +
</header>
 +
 +
</div>
 +
 +
<div class="fh5co-hero fh5co-hero-2">
 +
<div class="fh5co-overlay"></div>
 +
<div class="fh5co-cover fh5co-cover_2 text-center" data-stellar-background-ratio="0.5" style="background-image: url(images/about-image.jpg);">
 +
<div class="desc animate-box">
 +
<h2>Parts</h2>
 +
 +
</div>
 +
</div>
 +
</div>
 +
<!-- end:header-top -->
 +
<div id="fh5co-about">
 +
<div class="container">
 +
<div class="row">
 +
<div class="col-md-8 col-md-offset-2 text-center heading-section animate-box">
 +
<h3>Contribution</h3>
 +
 +
</div>
 +
</div>
 +
</div>
 +
<div class="container">
 +
<div class="row">
 +
<div class="col-md-8 col-md-offset-2 animate-box">
 +
 +
<p>
 +
During the use biobrick parts or biological devices (like a promoter), it is very limited to use the EcoR1, SpeI, XbaI, PstI enzyme sites for the insert gene. To compensate for this restriction, we’ve decided to use the primer design used in infusion cloning.
 
</p>
 
</p>
−
</div>
+
</div>
 +
</div>
 +
<div class="row">
 +
<div class="col-md-8 col-md-offset-2 animate-box">
 +
 +
<p> 1. It is difficult to identify whether the Anderson promoter is ligated to the vector since the Anderson promoter is only 33bp. Thus, according to the other teams as well, the Anderson promoter wasn’t ligated into the 3a assembly and amplified. Instead, they’ve redesigned the oligo of the Anderson promoter(5' EcoR1 overhang---- 3' spe1 3'over hang) and used the annealing method. However, TNCR Korea used a different method in hopes of using the anderson promoters that enable gene expression control. If we use the infusion primer design and attach the Anderson promoter at the primer and go through PCR the Anderson promoter will naturally amplify. We can identify this with the PCR product bend test. This is because if the primer doesn’t work, we won’t be able to identify the bend.</p>
 +
</div>
 +
</div>
 +
<div class="row">
 +
<div class="col-md-8 col-md-offset-2 animate-box">
 +
 +
<p>
 +
2. Like DPP4, if there are EcoR1, Spe1, Xba1, Pst1 site which are used in 3A assembly, it is read as illegal insert gene which is unable to use. Thus, a step that changes a sequence like point mutation is required which is infusion cloning. Ligation utilized in infusion cloning only requires cutting a vector, not enzyme cut of the insert gene. This is because, insert gene naturally inserts itself into vector while it is amplified by PCR with primer sequence.
 +
</p>
 +
</div>
 +
</div>
 +
 +
 
 +
</div>
 +
</div>
 +
 +
 +
<!-- fh5co-blog-section -->
 +
<footer>
 +
<div id="footer">
 +
<div class="container">
 +
<div class="row">
 +
<div class="col-md-6 col-md-offset-3 text-center">
 +
<p class="fh5co-social-icons">
 +
 
 +
</p>
 +
<p>Copyright 2016 Free Html5 <a href="#">TNCR_KOREA</a>. All Rights Reserved. <br>Made with <i class="icon-heart3"></i> by <a href="http://freehtml5.co/" target="_blank">Freehtml5.co</a> / Demo Images: <a href="https://unsplash.com/" target="_blank">Unsplash</a></p>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</footer>
 +
 +
 
 +
</div>
 +
<!-- END fh5co-page -->
  
 +
</div>
 +
<!-- END fh5co-wrapper -->
  
 +
<!-- jQuery -->
  
  
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_jquery_min/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<!-- jQuery Easing -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_jquery_easing_1_3/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<!-- Bootstrap -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_bootstrap_min/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<!-- Waypoints -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_jquery_waypoints_min/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<!-- Stellar -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_jquery_stellar_min/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<!-- Superfish -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_hoverIntent/Javascript?
 +
action=raw&ctype=text/javascript"></script>
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_superfish/Javascript?
 +
action=raw&ctype=text/javascript"></script>
  
 +
<!-- Main JS (Do not remove) -->
 +
<script src="https://2017.igem.org/Template:TNCR_Korea_main/Javascript?
 +
action=raw&ctype=text/javascript"></script>
  
 +
</body>
 
</html>
 
</html>

Latest revision as of 03:49, 2 November 2017

TNCR_KOREA — Digestable Gluten

Parts

Contribution

During the use biobrick parts or biological devices (like a promoter), it is very limited to use the EcoR1, SpeI, XbaI, PstI enzyme sites for the insert gene. To compensate for this restriction, we’ve decided to use the primer design used in infusion cloning.

1. It is difficult to identify whether the Anderson promoter is ligated to the vector since the Anderson promoter is only 33bp. Thus, according to the other teams as well, the Anderson promoter wasn’t ligated into the 3a assembly and amplified. Instead, they’ve redesigned the oligo of the Anderson promoter(5' EcoR1 overhang---- 3' spe1 3'over hang) and used the annealing method. However, TNCR Korea used a different method in hopes of using the anderson promoters that enable gene expression control. If we use the infusion primer design and attach the Anderson promoter at the primer and go through PCR the Anderson promoter will naturally amplify. We can identify this with the PCR product bend test. This is because if the primer doesn’t work, we won’t be able to identify the bend.

2. Like DPP4, if there are EcoR1, Spe1, Xba1, Pst1 site which are used in 3A assembly, it is read as illegal insert gene which is unable to use. Thus, a step that changes a sequence like point mutation is required which is infusion cloning. Ligation utilized in infusion cloning only requires cutting a vector, not enzyme cut of the insert gene. This is because, insert gene naturally inserts itself into vector while it is amplified by PCR with primer sequence.